Deregulation of FGFR2 gene has been reported in different human pathologies, such as melanoma and thyroid, breast, lung, gastric and ovarian cancers, in which up or downmodulation of KGFR expression has been observed in epithelial cells [63]–[67]. Here, FGFR2 is linked to ovarian carcinoma.